Ibnsina Pharma (CAI:ISPH) Long-Term Capital Lease Obligation : E£614 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Long-Term Capital Lease Obligation?

Ibnsina Pharma's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was E£614 Mil.

Ibnsina Pharma's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (E£398 Mil) to Dec. 2023 (E£620 Mil) but then declined from Dec. 2023 (E£620 Mil) to Mar. 2024 (E£614 Mil).

Ibnsina Pharma's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (E£225 Mil) to Dec. 2022 (E£282 Mil) and increased from Dec. 2022 (E£282 Mil) to Dec. 2023 (E£620 Mil).

Ibnsina Pharma Long-Term Capital Lease Obligation Historical Data

The historical data trend for Ibnsina Pharma's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Long-Term Capital Lease Obligation Chart

Ibnsina Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

34.12

26.27

224.80

281.67

620.42

Ibnsina Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															267.56	257.31	397.57	620.42	614.12

Ibnsina Pharma (CAI:ISPH) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Ibnsina Pharma Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma (CAI:ISPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrial zone 1, PO box 91, Obour, EGY

Website

http://www.ibnsina-pharma.com

Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines